Related references
Note: Only part of the references are listed.Alternative Splicing of ALS Genes: Misregulation and Potential Therapies
Benedetta Perrone et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation
Magdalena Koczkowska et al.
GENETICS IN MEDICINE (2019)
More than a messenger: Alternative splicing as a therapeutic target
A. J. Black et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders
Robert S. Porter et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Neurogenesis: Regulation by Alternative Splicing and Related Posttranscriptional Processes
Enrique Lara-Pezzi et al.
NEUROSCIENTIST (2017)
Emerging genotype-phenotype relationships in patients with large NF1 deletions
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2017)
Neurofibromatosis type 1
David H. Gutmann et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Alternative splicing and cell survival: from tissue homeostasis to disease
Maria Paola Paronetto et al.
CELL DEATH AND DIFFERENTIATION (2016)
Spatio-temporal regulations and functions of neuronal alternative RNA splicing in developing and adult brains
Takatoshi Iijima et al.
NEUROSCIENCE RESEARCH (2016)
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation
Kitiwan Rojnueangnit et al.
HUMAN MUTATION (2015)
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Elina Uusitalo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1
David W. Sant et al.
JOURNAL OF MEDICAL GENETICS (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
Audrey Sabbagh et al.
HUMAN MUTATION (2013)
Alternative splicing of the neurofibromatosis type I pre-mRNA
Victoria A. Barron et al.
BIOSCIENCE REPORTS (2012)
Neurofibromatosis type 1: from genotype to phenotype
Eric Pasmant et al.
JOURNAL OF MEDICAL GENETICS (2012)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1
Audrey Sabbagh et al.
HUMAN MOLECULAR GENETICS (2009)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
Quantitative and evolutionary biology of alternative splicing: how changing the mix of alternative transcripts affects phenotypic plasticity and reaction norms
J. H. Marden
HEREDITY (2008)
Splicing in disease: disruption of the splicing code and the decoding machinery
Guey-Shin Wang et al.
NATURE REVIEWS GENETICS (2007)
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1
Ophelia Maertens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies
Jessica J. Hawes et al.
NEUROGENETICS (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing
Eva Pros et al.
HUMAN MUTATION (2006)
Neurofibromin:: a general outlook
A. B. Trovo-Marqui et al.
CLINICAL GENETICS (2006)
Double inactivation of NF1 in tibial pseudarthrosis
DA Stevenson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects
KM Reilly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Novel and Recurrent Mutations in the NF1 Gene in Italian Patients with Neurofibromatosis Type 1
Alessandro De Luca et al.
HUMAN MUTATION (2004)
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
RM Costa et al.
NATURE (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1
RM Costa et al.
NATURE GENETICS (2001)
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
KM Reilly et al.
NATURE GENETICS (2000)
Share Paper
